InvestorsHub Logo
Followers 44
Posts 10483
Boards Moderated 0
Alias Born 01/13/2016

Re: Millstone post# 77510

Saturday, 11/26/2016 5:57:13 PM

Saturday, November 26, 2016 5:57:13 PM

Post# of 469661
Nicely written. In retrospect, it's nice to dissect developments "pre mono-therapy confirmation" now that we know. IMO we know that that the MMSE chart from 3 month to 6 month was confirmatory of "SOC" and I believe Biogen would have had access to that data. So Biogen figured out a way to get its foot in the door by throwing MS at Anavex.. Brilliant move on Biogens part! The good Dr would not have turned away the opportunity to help other sufferers quicker.
What do you think the reaction inside Biogen was when they saw the MonoTherapy Data from 2 years back for A2-73 Patients?

Do you think they are going to wait until after Dec 8th to make an offer?
Would you?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News